甘草酸二铵联合胸腺素α1 对病毒性肝炎患者血清胆碱酯酶、胆汁酸水平的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R512.6

基金项目:


Effect of Diammonium Glycyrrhizinate Combined with Thymosin α1 on Levels of Serum Cholinesterase and Total Bile Acids in Patients with Viral Hepatitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察甘草酸二铵联合胸腺素α1(Tα1) 对病毒性肝炎患者血清胆碱酯酶(CHE)、胆汁酸(TBA) 水平的影响。方法:选取110 例病毒性肝炎患者作为研究对象,按照分层抽样法分为对照组和联合组各55 例。对照组采用Tα1 治疗,联合组在对照组基础上加服甘草酸二铵治疗。分析2 组治疗前后总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、CD3+、CD4+、CD8+、白蛋白(Alb)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、总胆红素(TBil)、TBA、Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(Ⅳ-C)、层粘连蛋白(LN)、CHE 水平,并计算CD4+/CD8+。比较2 组临床疗效及不良反应发生情况。结果:与同组治疗前比较,2 组治疗后TC、TG、HDL-C、LDL-C、CD8+、AST、ALT、TBil、PCⅢ、Ⅳ-C、LN、TBA 水平均降低(P<0.05),CD3+、CD4+、Alb、CHE 水平及CD4+/CD8+均升高(P<0.05);与对照组治疗后比较,联合组治疗后TC、TG、HDL-C、LDL-C、CD8+、AST、ALT、TBil、PCⅢ、Ⅳ-C、LN、TBA 水平均较低(P<0.05),CD3+、CD4+、Alb、CHE 水平及CD4+/CD8+均较高(P<0.05)。联合组总有效率为98.18%,高于对照组的85.45%(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:甘草酸二铵联合Tα1 可有效缓解病毒性肝炎患者临床症状,提高CHE水平,降低TBA 水平,改善肝功能,有一定的抗肝纤维化作用。

    Abstract:

    Abstract:Objective:To observe the effect of diammonium glycyrrhizinate combined with thymosin α1(Tα1) on levels of serum cholinesterase(CHE) and total bile acids(TBA) in patients with viral hepatitis. Methods:A total of 110 patients with viral hepatitis were selected and divided into the control group and the combination group according to stratified sampling method, 55 cases in each group. The control group was treated with Tα1, and the combination group was additionally treated with diammonium glycyrrhizinate based on the treatment of the control group. The levels of total cholesterol(TC),triglyceride(TG), high density lipoprotein cholesterol(HDL- C), low density lipoprotein cholesterol(LDL- C), CD3 + , CD4 + , CD8 + , albumin (Alb), aspartate aminotransferase(AST), alanine aminotransferase(ALT), total bilirubin(TBil), TBA, procollagen Ⅲ(PC Ⅲ), Type Ⅳ collagen(Ⅳ-C),laminin(LN) and CHE before and after treatment in the two groups were analyzed. The value of CD4+ over CD8+ was calculated. The clinical effect and the incidence of adverse reactions were compared between the two groups. Results:Compared with those before treatment,the levels of TC,TG,HDL-C,LDL-C,CD8+,AST,ALT,TBil,PCⅢ, Ⅳ-C,LN and TBA were all decreased in both groups after treatment(P<0.05);the levels of CD3+,CD4+,Alb,CHE and CD4+/CD8+ were increased(P<0.05). the levels of TC,TG,HDL-C,LDL-C,CD8+,AST,ALT,TBil,PCⅢ,Ⅳ-C,LN and TBA in the combination group were lower than those in the control group(P<0.05),and the levels of CD3+,CD4+,Alb, CHE and CD4+/CD8+ were higher(P<0.05). The total effective rate was 98.18% in the combination group,higher than that of 85.45% in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05). Conclusion: Diammonium glycyrrhizinate combined with Tα1 can effectively alleviate the clinical symptoms of patients with viral hepatitis,increase CHE level,reduce TBA level and improve liver function,which has a antiliver fibrosis effect.

    参考文献
    相似文献
    引证文献
引用本文

张国栋.甘草酸二铵联合胸腺素α1 对病毒性肝炎患者血清胆碱酯酶、胆汁酸水平的影响[J].新中医,2021,53(16):96-100

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-08-23
  • 出版日期: